ESC Professional Premium Access

Problem-solving in antiplatelet therapy and anticoagulation

Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session type: Symposium
Date: 26 August 2022
Time: 08:30 - 10:00

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

6 presentations in this session

Reversal agents to improve safety in patients treated with antiplatelet P2Y12 inhibitors.

Speaker: Professor D. Bhatt (Boston, US)
Thumbnail

Reversal agents to improve safety in patients treated with direct oral anticoagulants (DOACs).

Speaker: Associate Professor A. Niessner (Vienna, AT)
Thumbnail

P2Y12 inhibitor monotherapy in patients undergoing PCI.

Speaker: Doctor D. Angiolillo (Jacksonville, US)
Thumbnail

Injectable and intravenous P2Y12 inhibitors in patients with acute myocardial infarction.

Speaker: Professor G. Montalescot (Paris, FR)
Thumbnail

Factor XIa inhibitors: a new approach to anticoagulation in patients with cardiovascular disease.

Speaker: Doctor J. Weitz (Hamilton, CA)
Thumbnail

Problem-solving in antiplatelet therapy and anticoagulation – discussion.

Thumbnail

5 speakers from this session

Professor Deepak Bhatt

Harvard Medical School, Boston (United States of America)
36 presentations
2 followers

Associate Professor Alexander Niessner

Medical University of Vienna, Vienna (Austria)
6 presentations
1 follower

Doctor Dominick Joseph Angiolillo

University of Florida College of Medicine, Jacksonville (United States of America)
23 presentations
1 follower

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20 presentations
0 follower

This platform is supported by

logo Novo Nordisk